ArticleHealthcare (Basel, Switzerland)2022
COVID-19 Pneumonia Classification Based on NeuroWavelet Capsule Network.
Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Screening Lung Diseases Using Cascaded Feature Generation and Selection Strategies.Healthcare (Basel, Switzerland) · 2022Article
- COVID-19 Diagnosis from Chest X-ray Images Using a Robust Multi-Resolution Analysis Siamese Neural Network with Super-Resolution Convolutional Neural Network.Diagnostics (Basel, Switzerland) · 2022Article
- Challenges of deep learning methods for COVID-19 detection using public datasets.Informatics in medicine unlocked · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since it was first reported, coronavirus disease 2019, also known as COVID-19, has spread expeditiously around the globe. COVID-19 must be diagnosed as soon as possible in order to control the disease and provide proper care to patients. The chest X-ray (CXR) has been identified as a useful diagnostic tool, but the disease outbreak has put a lot of pressure on radiologists to read the scans, which could give rise to fatigue-related misdiagnosis. Automatic classification algorithms that are reliable can be extremely beneficial; however, they typically depend upon a large amount of COVID-19 data for training, which are troublesome to obtain in the nick of time. Therefore, we propose a novel method for the classification of COVID-19. Concretely, a novel neurowavelet capsule network is proposed for COVID-19 classification. To be more precise, first, we introduce a multi-resolution analysis of a discrete wavelet transform to filter noisy and inconsistent information from the CXR data in order to improve the feature extraction robustness of the network. Secondly, the discrete wavelet transform of the multi-resolution analysis also performs a sub-sampling operation in order to minimize the loss of spatial details, thereby enhancing the overall classification performance. We examined the proposed model on a public-sourced dataset of pneumonia-related illnesses, including COVID-19 confirmed cases and healthy CXR images. The proposed method achieves an accuracy of 99.6%, sensitivity of 99.2%, specificity of 99.1% and precision of 99.7%. Our approach achieves an up-to-date performance that is useful for COVID-19 screening according to the experimental results. This latest paradigm will contribute significantly in the battle against COVID-19 and other diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.